Translational Relevance.
Clinical observations, validated in an animal model in the laboratory, have yielded conceptual foundations for new clinical treatments of cancer.
Unexpectedly positive outcomes from an unusual hormone and radiation schedule led to the theory that the treatment triggered an acute adaptive immune response.
To validate this concept, an acute innate immune response was stimulated in an animal model using cluster vaccination with Poly I:C. In the presence of exogenous cancer-specific antigens, this immune response adapted itself to create an abscopal effect which resulted in cancer resolution.
These concepts may be translated back to the clinic in order to improve treatment outcomes. This paper reviews historical evidence of abscopal effects in cancer, and discusses the relationship between infection and cancer regression as it relates to immune signalling. It then proposes ways to amplify standard cancer treatments to induce systemic abscopal effects.
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Research.
In the 1990s, the British Columbia Cancer Agency had a waiting list for treatment of prostate cancer patients of up to one year, which had developed over time through a shortage of treatment facilities. As a holding measure, all prostate cancer patients were given hormone therapy while waiting for radiation; specifically, androgen withdrawal therapy, which caused initial remission of prostate cancer. Hormone therapy was discontinued at the completion of radiation. Overall cancer outcomes were unchanged, but in subset analysis, patients with poorly differentiated cancer (Gleason 8-10) had better outcomes than expected 1, 2, 3, 4 . The benefit was independent of the duration of hormone treatment but was seen in those whose Prostate Specific Antigen (PSA) indicated full remission before radiation started and only in poorly differentiated cancers. These patients had a significant decrease in death from prostate cancer. A randomized multi centred study carried out across Canada confirmed these results, with no difference in outcome or survival in the overall group but improved outcomes and survival for the patients with the worst prognosis 5 .
Poorly differentiated prostate cancers (Gleason 8-10), tend to spread early, and death from prostate cancer is due to metastatic rather than local disease. Our data suggested that hormone therapy prior to radiation of the primary tumour site may produce systemic changes which 'prime the system'; local radiation may then induce systemic control of cancer at the metastasized sites as well as the primary site. This phenomenon has been reported as the 'abscopal effect' -the regression of distant disease after localized treatment 14, 15 . The cross recognition and presentation of cancer antigen has been shown to boost the effector CD8 T cell expansion 16 . Unfortunately, in many tumour settings, and particularly in prostate cancer, well defined and highly reliable tumour antigens that can be targeted with synthetic vaccines are often non-existent, although antigen discovery efforts are underway around the world to hopefully define future vaccine candidates.
We hypothesize that the clinical response that we have previously observed and attributed to abscopal effects are the result of immunogenic prostate cancer antigens which are released by the tumour necrosis caused by radiation therapy.
The effect is seen when hormone therapy has been maximised, as reflected in the PSA level 17 . Androgen withdrawal hormone therapy is known to shut down gene expression 18 and change the cellular and membrane environment 19 , which may change tolerance and enable cancer cell recognition by the immune system. These DAMPS augment the presentation of tumour antigens released from necrotic tumour cells 20, 22 , ultimately inducing the immune system to attack cancer and thereby mimicking an acute infection. DAMPs and PAMPs may share some commonality of expression and it may be possible to evoke an acute anticancer immune response using an 'endogenous' vaccine approach. The response to DAMPs produced by sterile necrosis caused by conventional treatment could be amplified by local delivery of PAMP compounds to emulate the Coley phenomenon. In our prostate cancer therapy, we used a sequence of hormone therapy to change the molecular environment prior to causing cancer necrosis and inflammation with radiation. Radiation death of poorly differentiated cancer cells is usually by necrosis, while well differentiated cancer cells die by apoptosis, without necrosis or signalling 23 . This difference may explain the lack of benefit in our overall series, and focuses the need for immune based treatment strategies capable of causing necrotic cancer damage that will induce inflammation and DAMPS signalling. That cancer abscopal effects can occur without an exogenous foreign danger signal (PAMP) has been shown in studies of radiation with amplification of the dendritic cell recognition pathway 6 , or by using TLR agonist along with tumour specific antigen 15 . Therefore while all three components of the acute infection danger signal, inflammation, necrosis and PAMPs, may not be required to invoke a systemic abscopal response, the sequencing and intensity of those used may be critical.
We anticipate that it may be beneficial to design conventional treatments that maximise immune signalling from endogenous vaccines produced by necrotic . Similar systemic amplification of focussed localized radiation followed by interleukin-2 has resulted in metastatic cancer resolution in renal cell and melanoma patients with an increase in CD4 and memory cells 26 . The degree and balance of amplification necessary will depend on the innate immunogenicity of the individual cancer; the toxicity may be minimized by local treatment at the cancer site 20 . A successful sequence would achieve anti-tumour immunity that is both potent and long-lived and will have the desired abscopal effect on metastatic tumour sites. The sequence, amount and timing of events will be critical to initiate an acute infectious type of response to cancer and it's antigen which has been able to evade immune surveillance by inducing central and peripheral tolerance. This stratagem opens the way for novel cancer 
